DOMINIQUE FAGET/AFP/Getty Images
About 1,850 people have died in the current Ebola outbreak in West Africa.
Treating Ebola patients with blood or purified serum of disease survivors should be a priority in the fight against the outbreak in West Africa, an expert panel organized by the World Health Organization (WHO) said on 5 September.
The recommendation came at the end of a two-day meeting to determine which experimental Ebola therapies and vaccines should be prioritised for accelerated clinical development. The WHO estimates that roughly 3,700 people have been infected in West Africa, and about 1,850 have died.
Marie-Paule Kieny, WHO assistant director-general for health systems and innovation, told reporters that the transfusion of whole blood or purified serum from Ebola survivors was the therapy with the greatest potential to be implemented immediately on a large scale in West Africa — in part because the outbreak’s size means there are many potential donors available. The idea is to transfer antibodies against Ebola from survivors to sufferers, but there is little information on the efficacy of such transfusions.